首页> 美国卫生研究院文献>OncoTargets and therapy >Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance
【2h】

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance

机译:UHRF2在肝内胆管癌中的过表达及其临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) has been implicated in tumorigenesis. However, its roles in intrahepatic cholangiocarcinoma (ICC) are still unclear. In this study, UHRF2 expression was analyzed in several kinds of cancers by referring to public Oncomine database, and the levels of UHRF2 mRNA and protein were determined in ICC cells and tissues. Then, the roles of UHRF2 in ICC were investigated by UHRF2 interference. Moreover, the relationship between UHRF2 and E-cadherin expression was examined in ICC cells and samples. Finally, the prognostic role of UHRF2 in ICC was analyzed in 139 ICC patients by Cox regression and Kaplan–Meier methods. We found UHRF2 was overexpressed in multiple human cancers, as well as in ICC, and the invasion, migration, proliferation, and antiapoptosis of ICC cells were inhibited by UHRF2 interference. Moreover, the epithelial–mesenchymal transition-related marker E-cadherin was upregulated in ICC cells which was influenced by UHRF2 expression. Clinically, UHRF2 expression was positively associated with microvascular invasion and lymphatic metastasis of ICC, and patients in the UHRF2high group had much lower overall survival and higher recurrence rates than patients in the UHRF2low group. A multivariate analysis revealed that UHRF2 overexpression was a new prognostic marker for ICC. Thus, our results indicated that high level of UHRF2 might be a novel predictor for the prognosis of ICC.
机译:具有PHD和无名指结构域2(UHRF2)的泛素样蛋白已与肿瘤发生有关。然而,其在肝内胆管癌(ICC)中的作用仍不清楚。在这项研究中,参考公共Oncomine数据库分析了UHRF2在几种癌症中的表达,并确定了ICC细胞和组织中UHRF2 mRNA和蛋白的水平。然后,通过UHRF2干扰研究了UHRF2在ICC中的作用。而且,在ICC细胞和样品中检查了UHRF2和E-钙粘蛋白表达之间的关系。最后,通过Cox回归和Kaplan–Meier方法分析了139例ICC患者中UHRF2在ICC中的预后作用。我们发现UHRF2在多种人类癌症以及ICC中过表达,并且UHRF2干扰抑制了ICC细胞的侵袭,迁移,增殖和抗凋亡。此外,上皮-间质转化相关标志物E-钙粘蛋白在ICC细胞中被上调,受UHRF2表达的影响。在临床上,UHRF2表达与ICC的微血管浸润和淋巴结转移呈正相关,并且UHRF2 high 组的患者的总生存率和复发率要比UHRF2 low 低的患者低得多。 sup>组。多变量分析显示,UHRF2过表达是ICC的新预后标志物。因此,我们的结果表明,高水平的UHRF2可能是ICC预后的新预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号